Page 8 - Ron Menezes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MISSION PLASTICOS ANNOUNCES APPOINTMENT OF NEW RESHAPING LIVES AMERICA COUNCIL OF TRUSTEES MEMBER, N BILL AYDIN, MD, FACS

ORANGE COUNTY, Calif., March 21, 2022 /PRNewswire/ Mission Plasticos, a 501-c3 non-profit organization dedicated to providing reconstructive su.

United statesOrange countyRon menezesLucia petruccelliArash khazeiSusan williamsonCouncil of trusteesMission plasticos reshapingMission plasticosAmerica council of trusteesSientra incAydin centerReshaping lives america councilPlastic surgeryLives america councilReshaping lives america

Sientra closes sale of miraDry at $10M loss | Pacific Coast Business Times

Sientra closes sale of miraDry at $10M loss | Pacific Coast Business Times
pacbiztimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pacbiztimes.com Daily Mail and Mail on Sunday newspapers.

United statesRon menezesExchange commissionMiramar labsஒன்றுபட்டது மாநிலங்களில்ரோன் மெனிசஸ்பரிமாற்றம் தரகுமீரமர் ஆய்வகங்கள்

Sientra Announces Addition of Vice President of Research &

Sientra Announces Addition of Vice President of Research & Development June 01, 2021 16:01 ET | Source: Sientra, Inc. Sientra, Inc. Santa Barbara, California, UNITED STATES SANTA BARBARA, Calif., June 01, 2021 (GLOBE NEWSWIRE) Sientra, Inc. (NASDAQ: SIEN) (“Sientra or the “Company ), a medical aesthetics company uniquely focused on plastic surgeons, today announced the appointment of Denise Dajles as Vice President of Research & Development, effective today. In this new role, Ms. Dajles will report to Chief Executive Officer Ron Menezes and lead Sientra’s R&D and medical affairs teams. We are pleased to welcome Denise to the Sientra management team, said Ron Menezes, President and CEO of Sientra. With her considerable technical and international expertise, Denise is well-suited to lead our R&D organization as we pursue our goal to be the leader in bringing transformative treatments and technologies to market that

United statesCosta ricaRon menezesSanta barbaraAsia pacificCompany breast productsSientra incResearch developmentBiomedical engineering labWashington universityGeorge washington universityUniversity of costa rica school engineeringDenise dajlesVice presidentChief executive officer ron menezesSenior director

Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results

Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth Results driven by Sientra’s continued investment and market outperformance in the core breast products segment SANTA BARBARA, Calif., Feb. 04, 2021 Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2020. Ron Menezes, President and Chief Executive Officer of Sientra, stated, “As the only breast aesthetics company committed exclusively to the plastic surgery channel, Sientra is focused on becoming the leader in novel treatments that progress the art of plastic surgery. Throughout 2020, Sientra increased investment in our breast aesthetics business, expanding our salesforce and production capacity, a

United statesRon menezesSanta barbaraExchange commissionSecurities exchangeSientra incCompany breast products segmentBreast productsChief executive officerFull yearSientra gel sizerSaline sizerBreast products segmentDry segmentSecurities actSecurities exchange act

Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results Sientra, Inc.February 4, 2021 GMT Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth Results driven by Sientra’s continued investment and market outperformance in the core breast products segment SANTA BARBARA, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2020.

United statesRon menezesSanta barbaraExchange commissionSecurities exchangeSientra incCompany breast products segmentBreast productsChief executive officerFull yearSientra gel sizerSaline sizerBreast products segmentDry segmentSecurities actSecurities exchange act